CA2209893A1 - Lantibiotique provenant de streptococcus mutans, methode de production et utilisation - Google Patents

Lantibiotique provenant de streptococcus mutans, methode de production et utilisation

Info

Publication number
CA2209893A1
CA2209893A1 CA 2209893 CA2209893A CA2209893A1 CA 2209893 A1 CA2209893 A1 CA 2209893A1 CA 2209893 CA2209893 CA 2209893 CA 2209893 A CA2209893 A CA 2209893A CA 2209893 A1 CA2209893 A1 CA 2209893A1
Authority
CA
Canada
Prior art keywords
mutacin
polypeptide
isolated
amino acid
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2209893
Other languages
English (en)
Inventor
Christophe Lacroix
Marc Lavoie
Marilaine Mota-Meira
Gisele Lapointe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Laval
Original Assignee
Universite Laval
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Laval filed Critical Universite Laval
Priority to CA 2209893 priority Critical patent/CA2209893A1/fr
Publication of CA2209893A1 publication Critical patent/CA2209893A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
CA 2209893 1997-09-08 1997-09-08 Lantibiotique provenant de streptococcus mutans, methode de production et utilisation Abandoned CA2209893A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2209893 CA2209893A1 (fr) 1997-09-08 1997-09-08 Lantibiotique provenant de streptococcus mutans, methode de production et utilisation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2209893 CA2209893A1 (fr) 1997-09-08 1997-09-08 Lantibiotique provenant de streptococcus mutans, methode de production et utilisation

Publications (1)

Publication Number Publication Date
CA2209893A1 true CA2209893A1 (fr) 1999-03-08

Family

ID=4161032

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2209893 Abandoned CA2209893A1 (fr) 1997-09-08 1997-09-08 Lantibiotique provenant de streptococcus mutans, methode de production et utilisation

Country Status (1)

Country Link
CA (1) CA2209893A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way

Similar Documents

Publication Publication Date Title
Ross et al. Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3
Novak et al. Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans
Mota-Meira et al. Purification and structure of mutacin B-Ny266: a new lantibiotic produced by Streptococcus mutans
EP0342486B1 (fr) Antibiotique
EP0871654A1 (fr) Protegrines
JP2010207227A (ja) 新規な抗菌性ポリペプチド及び使用方法
JPH09503383A (ja) プロテグリン
US6699839B1 (en) Lantibiotic from Streptococcus mutans, method of production and use thereof
EP1169340B1 (fr) Lantibiotique
EP0521240B1 (fr) Bactériocin de Lactococcus lactis sous-esphèce lactis
CA2256465A1 (fr) Blocage de l'expression de l'aggressine dans s. aureus
CA2623624A1 (fr) Variantes du lantibiotique mersacidine, et leur utilisation
EP2271665B1 (fr) Peptides hautement pontés provenant d'actinomadura namibiensis
US6964760B2 (en) Antimicrobial polypeptide, nucleic acid, and methods of use
CA2209893A1 (fr) Lantibiotique provenant de streptococcus mutans, methode de production et utilisation
US7067125B2 (en) Antimicrobial polypeptides and methods of use
US5861376A (en) Synthetically derived peptide
DK175198B1 (da) Antibioticum, betegnet gallidermin, og syreadditionssalte deraf, farmaceutiske og kosmetiske præparater indeholdende forbindelserne og fremgangsmåde til forbindelsernes fremstilling samt deres anvendelse til fremstilling af et farmaceutisk præparat
US20060198793A1 (en) Antimicrobial polypeptide, nucleic acid, and methods of use
Götz et al. Structure and DNA-Sequence Analysis of the Staphylococcal Lantibiotics Epidermin and Gallidermin
MX2008007342A (es) Peptidos inductores de baceriocina

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead